Evidence map›Paper›PMID 28730700›Full record

ArticleMicrobial biotechnology2017

Relating switching rates between normal and persister cells to substrate and antibiotic concentrations: a mathematical modelling approach supported by experiments.

Gabriel Carvalho, Cyril Guilhen, Damien Balestrino, Christiane Forestier, Jean-Denis Mathias

Abstract read
In one paragraph

Article in Microbial biotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Eradication of Drug-TolerantMicroorganisms · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Power-law tail in lag time distribution underlies bacterial persistence.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gabriel CarvalhoUR LISC Laboratoire d'ingénierie pour les systèmes complexes, Irstea, Aubière, France.
Cyril GuilhenLMGE, UMR6023 CNRS, Université Clermont Auvergne, Clermont-Ferrand, France.
Damien BalestrinoLMGE, UMR6023 CNRS, Université Clermont Auvergne, Clermont-Ferrand, France.
Christiane ForestierLMGE, UMR6023 CNRS, Université Clermont Auvergne, Clermont-Ferrand, France.
Jean-Denis MathiasUR LISC Laboratoire d'ingénierie pour les systèmes complexes, Irstea, Aubière, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We developed and compared two mathematical models of variable phenotypic switching rates between normal and persister cells that depend on substrate concentration and antibiotic presence. They could be used to simulate the formation of persisters in environments with concentration gradients such as biofilms. Our models are extensions of a previous model of the dynamics of normal and persistent cell populations developed by Balaban et al. (2004, Science 305: 1622). We calibrated the models' parameters with experimental killing curves obtained after ciprofloxacin treatment of samples regularly harvested from planktonic batch cultures of Klebsiella pneumoniae. Our switching models accurately reproduced the dynamics of normal and persistent populations in planktonic batch cultures and under antibiotic treatment. Results showed that the models are valid for a large range of substrate concentrations and for zero or high doses of antibiotics.

Indexed as

Anti-Bacterial AgentsBiofilmsKineticsKlebsiella pneumoniaeModels, TheoreticalAnti-Bacterial Agents

Identifiers

PMID28730700
PMCPMC5658594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.